Literature DB >> 30173223

How Does Continuous Renal Replacement Therapy Affect Septic Acute Kidney Injury?

Jingxiao Zhang1,2, Jiakun Tian1, Hongzhi Sun1, Kumar Digvijay2,3,4, Mauro Neri2,3, Vinant Bhargava4, Yongjie Yin1, Claudio Ronco2,3.   

Abstract

Sepsis is the leading cause of acute kidney injury (AKI) in the intensive care unit. As the most common treatment of septic AKI, it is believed that continuous renal replacement therapy (CRRT) can not only maintain the water balance and excrete the metabolic products but also regulate the inflammation and promote kidney recovery. CRRT can remove the inflammatory cytokines to regulate the metabolic adaption in kidney and restore the kidney recovery to protect the kidney in septic AKI. Second, CRRT can provide extra energy supply in septic AKI to improve the kidney energy balance in septic AKI. Third, the anticoagulant used in CRRT also regulates the inflammation in septic AKI. CRRT is not only a treatment to deal with the water balance and metabolic products, but also a method to regulate the inflammation in septic AKI.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Anticoagulation; Continuous renal replacement therapy; Metabolic adaptation; Septic acute kidney injury

Mesh:

Year:  2018        PMID: 30173223     DOI: 10.1159/000492026

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy.

Authors:  Thananda Trakarnvanich; Phatadon Sirivongrangson; Konlawij Trongtrakul; Nattachai Srisawat
Journal:  J Artif Organs       Date:  2022-04-12       Impact factor: 1.731

2.  Prognostic Prediction Using the Clinical Data and Ultrasomics-Based Model in Acute Respiratory Distress Syndrome (ARDS) Combined with Acute Kidney Injury (AKI).

Authors:  Xing Cai; Jing Li; Ping Qin; Peng An; Hao Yang; MingYan Zuo; Jinsong Wang
Journal:  Int J Clin Pract       Date:  2022-05-11       Impact factor: 3.149

3.  Clinical effect and safety of continuous renal replacement therapy in the treatment of neonatal sepsis-related acute kidney injury.

Authors:  Cheng Cai; Gang Qiu; Wenchao Hong; Yunlin Shen; Xiaohui Gong
Journal:  BMC Nephrol       Date:  2020-07-18       Impact factor: 2.388

Review 4.  Acute Kidney Injury in COVID-19: The Chinese Experience.

Authors:  Xizi Zheng; Youlu Zhao; Li Yang
Journal:  Semin Nephrol       Date:  2020-09-04       Impact factor: 5.299

5.  Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children.

Authors:  Lengyue Peng; Yawen Gao; Guangli Zhang; Xiaoyin Tian; Huiting Xu; Qinghong Yu; Jie Cheng; Yuanyuan Li; Qinyuan Li; Yingfu Chen; Wei Zhao; Zhengxiu Luo
Journal:  Ann Transl Med       Date:  2021-02

6.  The Effect of Long-Term Duration Renal Replacement Therapy on Outcomes of Critically Ill Patients with Acute Kidney Injury: A Retrospective Cohort Study.

Authors:  Mengmeng Yang; Yun Li; Peiyao Li; Yong Fan; Yu Zhang; Rui Yuan; Lu Wang; Yan Zhao; Xiaoli Liu; Zhengbo Zhang; Hongjun Kang
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-30       Impact factor: 2.629

7.  The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units.

Authors:  Zichen Wang; Luming Zhang; Fengshuo Xu; Didi Han; Jun Lyu
Journal:  BMC Emerg Med       Date:  2022-02-28

8.  Be aware of acute kidney injury in critically ill children with COVID-19.

Authors:  Xiaowen Wang; Xingfeng Chen; Feng Tang; Wanjun Luo; Jian Fang; Chang Qi; Hua Sun; Han Xiao; Xuehua Peng; Jianbo Shao
Journal:  Pediatr Nephrol       Date:  2020-08-26       Impact factor: 3.651

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.